Cargando…

Diagnostics and treatment of ovarian cancer in the era of precision medicine - opportunities and challenges

Due to predictions of increasing incidences and deaths from ovarian cancer, this neoplasm is a challenge for modern health care. The advent of NGS technology has made it possible to understand the molecular characteristics of many cancers, including ovarian cancer. The data obtained in research beca...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bukłaho, Patrycja Aleksandra, Kiśluk, Joanna, Nikliński, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10516548/ https://www.ncbi.nlm.nih.gov/pubmed/37746296 http://dx.doi.org/10.3389/fonc.2023.1227657

Ejemplares similares

Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
por: Ramroop, Johnny R., et al.
Publicado: (2018)

A New Era of Prostate Cancer Precision Medicine
por: Malik, Adil, et al.
Publicado: (2019)

Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine
por: Wang, Wanyan, et al.
Publicado: (2021)

Opportunities and Challenges of the Human Microbiome in Ovarian Cancer
por: Cheng, Huiyan, et al.
Publicado: (2020)

Increased MET Gene Copy Number but Not mRNA Level Predicts Postoperative Recurrence in Patients with Non–Small Cell Lung Cancer()
por: Kowalczuk, Oksana, et al.
Publicado: (2014)

Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities
por: Beckmann, Jacques S., et al.
Publicado: (2016)

Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology
por: Manne, Ashish, et al.
Publicado: (2021)

Preclinical models of pancreatic ductal adenocarcinoma: challenges and opportunities in the era of precision medicine
por: Yu, Yiqi, et al.
Publicado: (2021)

Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine
por: Kamran, Sophia C., et al.
Publicado: (2021)

Transnasal endoscopic skull base surgery in the COVID-19 era: Recommendations for increasing the safety of the method
por: Lyson, Tomasz, et al.
Publicado: (2021)

Application of Ovarian Cancer Organoids in Precision Medicine: Key Challenges and Current Opportunities
por: Yang, Jiani, et al.
Publicado: (2021)

Identification of Genetic Mutations in Cancer: Challenge and Opportunity in the New Era of Targeted Therapy
por: Jin, Jing, et al.
Publicado: (2019)

The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology
por: Shui, Lin, et al.
Publicado: (2021)

Quantitative Analyses of the Tumor Microenvironment Composition and Orientation in the Era of Precision Medicine
por: Petitprez, Florent, et al.
Publicado: (2018)

The value of stereotactic biopsy of primary and recurrent brain metastases in the era of precision medicine
por: Katzendobler, Sophie, et al.
Publicado: (2022)

Editorial: Management of borderline ovarian tumor: The best treatment is a real challenge in the era of precision medicine
por: Della Corte, Luigi, et al.
Publicado: (2023)

UPS: Opportunities and challenges for gastric cancer treatment
por: Yang, Hang, et al.
Publicado: (2023)

Challenges and opportunities for precision medicine in neurodevelopmental disorders
por: Chen, George T., et al.
Publicado: (2022)

Confronting the Care Delivery Challenges Arising from Precision Medicine
por: Kohn, Elise C., et al.
Publicado: (2016)

Early Access Provision for Innovative Medicinal Products in Oncology: Challenges and Opportunities
por: Krendyukov, Andriy
Publicado: (2020)

Challenges in precision medicine in pancreatic cancer: A focus in cancer stem cells and microbiota
por: Perelló-Reus, Catalina M., et al.
Publicado: (2022)

Artificial intelligence assists precision medicine in cancer treatment
por: Liao, Jinzhuang, et al.
Publicado: (2023)

Molecular Profiling–Based Precision Medicine in Cancer: A Review of Current Evidence and Challenges
por: Zhang, Qi, et al.
Publicado: (2020)

The Link Between the Microbiota and HER2+ Breast Cancer: The New Challenge of Precision Medicine
por: Di Modica, Martina, et al.
Publicado: (2022)

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness
por: Seymour, Christopher W., et al.
Publicado: (2017)

Disease Biomarkers for Precision Medicine: Challenges and Future Opportunities
por: Wang, Edwin, et al.
Publicado: (2017)

Precision medicine in severe pediatric asthma: opportunities and challenges
por: Vijverberg, Susanne J.H., et al.
Publicado: (2020)

Identification of protein changes in the blood plasma of lung cancer patients subjected to chemotherapy using a 2D-DIGE approach
por: Ciereszko, Andrzej, et al.
Publicado: (2019)

Policy Challenges for Organ Allocation in an Era of “Precision Medicine”
por: Caulfield, Timothy, et al.
Publicado: (2020)

Emerging Opportunities of Radiotherapy Combined With Immunotherapy in the Era of Breast Cancer Heterogeneity
por: Tsoutsou, Pelagia G., et al.
Publicado: (2018)

NTRK Fusions, from the Diagnostic Algorithm to Innovative Treatment in the Era of Precision Medicine
por: Zito Marino, Federica, et al.
Publicado: (2020)

Patient-derived models: Advanced tools for precision medicine in neuroblastoma
por: Aaltonen, Kristina, et al.
Publicado: (2023)

Opportunities and challenges of targeting c-Met in the treatment of digestive tumors
por: Zhang, Zhengchao, et al.
Publicado: (2022)

MicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine
por: Smith, Bethany, et al.
Publicado: (2017)

Precision medicine approaches for diabetic kidney disease: opportunities and challenges
por: Tye, Sok Cin, et al.
Publicado: (2021)

Precision medicine in human heart modeling: Perspectives, challenges, and opportunities
por: Peirlinck, M., et al.
Publicado: (2021)

Application of precision medicine in clinical routine in haematology—Challenges and opportunities
por: Wästerlid, Tove, et al.
Publicado: (2022)

Editorial: Exploiting DNA Damage Response in the Era of Precision Oncology
por: Zimmer, Yitzhak, et al.
Publicado: (2020)

Challenges and Opportunities Associated With Platelets in Pancreatic Cancer
por: Chen, Zhou, et al.
Publicado: (2022)

Ovarian Cancer: The Fallopian Tube as the Site of Origin and Opportunities for Prevention
por: George, Sophia H. L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m7ovc8e521do605bs7kf1s2m77